Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)

Clinical trial NCT01228019 · TERMINATED

Trial details

NCT number: NCT01228019
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Study type: OBSERVATIONAL

Hypercholesterolemia Mixed Dyslipidemia

Start date: 2010-12-01
Primary completion: 2013-05-01
Enrollment: 1166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.